Two water-soluble thiosemicarbazone-proline (H 2 L 1 ) and thiosemicarbazone-homoproline hybrids (H 2 L 2 ) were synthesised. By reaction of H 2 L 1 with NiCl 2 ·6H 2 O, PdCl 2 and CuCl 2 ·2H 2 O in ethanol, the series of square-planar complexes [Ni(H 2 L 1 )Cl]Cl·1.3H 2 O (1·1.3H 2 O), [Pd(H 2 L 1 )Cl]Cl·H 2 O (2·H 2 O) and [Cu(H 2 L 1 )Cl]-Cl·0.7H 2 O (3·0.7H 2 O) was prepared, and starting from H 2 L 2 and CuCl 2 ·2H 2 O in methanol, the complex [Cu(H 2 L 2 )Cl 2 ]·H 2 O (4·H 2 O) was obtained. The compounds have been characterised by elemental analysis, spectroscopic methods (IR, UV-vis and NMR spectroscopy), ESI mass spectrometry and single crystal X-ray crystallography (H 2 L 1 , 1, 2 and 4). As a solid, 1 is diamagnetic, while it is paramagnetic in methanolic solution.
Introduction
α-(N)-Heterocyclic thiosemicarbazones (TSCs) are a class of highly potent inhibitors of the ribonucleotide reductase (RNR) enzyme. 1, 2 RNR catalyses the reduction of all four ribonucleotides to their corresponding deoxyribonucleotides and thereby provides the precursors needed for both synthesis and repair of DNA. Currently, the most studied therapeutic compound among the thiosemicarbazones is Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone). It is by a factor of 1000 a more potent inhibitor of hR2 RNR activity than hydroxyurea, a clinically used RNR inhibitor. 3 Triapine has entered several phase II clinical trials as a chemotherapeutic agent. 4 However, this investigational drug showed severe side effects, while only a small response was observed. [5] [6] [7] [8] Another promising drug, di-2pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone (DpC), has just entered clinical trials, 9 but RNR is not or only in part responsible for its biological activity. † Electronic supplementary information (ESI) available: Synthesis pathway of H 2 L 2 (Scheme S1), ORTEP view of another crystallographically independent cation of 2 showing intermolecular hydrogen bonding interactions ( Fig. S1 ), fragments of the crystal structure of 1 and 2 revealing intermolecular Pd⋯S contacts between two crystallographically independent cations ( Fig. S2 and S3 ), COSY 1 H-1 H NMR spectra of 2 ( Fig. S4 and S5 ), UV-vis spectra of H 2 L 2 and 4 ( Fig. S6 and S7 ), hydrogen bonding interactions in 1 (Table S1 ) and selected matrix elements for simulation of 1 Many thiosemicarbazones are excellent chelators for transition metal ions, such as iron(II), copper(II) and zinc(II), typically coordinating via X, N, and S atoms, where X is the donor atom of the additional functional group of the aldehyde or ketone used for their preparation. 10 The coordination of these TSCs can result in metal complexes with a higher cytotoxicity than that of the ligand precursors. In addition, the enhanced need for the essential metal ions of cancer cells vs. healthy cells makes the development of new chelators as anticancer agents an important task. 11, 12 Copper(II) complexes are promising anticancer agents, 13 often exhibiting very high antiproliferative activity in vitro. In particular, copper(II) complexes with acyl diazine thiosemicarbazones bearing an N 4 -azabicyclo[3.2.2]nonane group showed cytotoxic activity against colon adenocarcinoma HT-29 cells with IC 50 values ranging from 4 nM to 1.51 µM and human acute lymphoblastic leukemia CCRF-CEM cells with IC 50 values ranging from 5 nM to 1.16 µM. 14 Recently a series of copper(II)-TSC complexes have been tested for their topoisomerase IIα inhibition activity with the conclusion that these complexes are more potent topoisomerase IIα inhibitors than the corresponding ligand precursors. 15 One such copper(II) complex was [CuLCl] , where HL = 2-pyridinealdehyde 4-N-ethylthiosemicarbazone. The main prerequisite for their topoisomerase IIα inhibition properties was suggested to be the square-planar coordination geometry of copper(II) in these complexes.
Despite their high cytotoxicity in vitro, a low water solubility, high lipophilicity and high in vivo toxicity are the main disadvantages of TSC compounds as anticancer agents, 16 so one of the current challenges is the design of new active TSCs and their metal complexes with enhanced aqueous solubility 17 and a priori oriented towards a cancer specific target. 18 We have shown that 2-hydroxybenzaldehyde thiosemicarbazone (STSC) can be coupled to L-or D-proline (Pro) leading to hybrids with enhanced aqueous solubility. 19 Although these new systems show only moderate cytotoxic potency with IC 50 values of 62 and 75 µM, respectively, in ovarian carcinoma CH1 cells and >100 µM in colon carcinoma SW480 cells, the coordination of these ligands to copper(II) resulted in a 13-and 5-fold increase in cytotoxicity in CH1 cells, based on a comparison of IC 50 values, while in SW480 cells the enhancement of the antiproliferative activity was even higher. In both tested cell lines, L-Pro-STSC as well as its copper(II) complex showed slightly stronger antiproliferative activity than the compounds with a D-Pro moiety, yielding IC 50 values of 4.6 and 5.5 µM for [Cu(L-Pro-STSC)Cl]Cl in CH1 and SW480 cells, respectively. 19 Moreover, the preliminary data from the screening of the topoisomerase IIα inhibiting activity indicate that the square-planar copper(II) complexes prepared by us are indeed potential inhibitors of the topoisomerase IIα enzyme in contrast to the corresponding metal-free conjugates, which are devoid of such activity.
The quite recently reported results 19 prompted us to prepare new 2-hydroxybenzaldehyde thiosemicarbazones substituted at the terminal nitrogen atom to enhance the lipophilicity and coupled to two related αand β-amino acid homologs, namely proline and homoproline. We anticipated that these new conjugates will form square-planar metal complexes enabling the elucidation of (i) the role of the squareplanar coordination geometry of the metal complexes in the underlying mechanism of antiproliferative activity, (ii) the effect of metal coordination and (iii) substitution at the terminal nitrogen atom of the thiosemicarbazide moiety, and (iv) the effect of the homologisation of proline to β 3 -homoproline on antiproliferative activity in cancer cell lines. Herein we report on the synthesis of two organic conjugates, namely 5-methyl-2-hydroxybenzaldehyde 4-N-pyrrolidine-3-thiosemicarbazone coupled to L-proline and β 3 -homoproline, respectively, and four new complexes with nickel(II), palladium(II) and copper(II) (Chart 1), their characterisation by elemental analysis, spectroscopic methods, and X-ray crystallography, and their antiproliferative activity in three human cancer cell lines (A549, CH1 and SW480) and noncancerous murine fibroblasts (NIH/3T3). Clear-cut structure-activity relationships (SARs) were established and discussed.
Experimental section

Chemicals
All reagents were used as purchased from commercial suppliers. L-Proline was from Alfa Aesar. 4-Pyrrolidine-3-thiosemicarbazide 20 was obtained in 60% yield by refluxing methyl hydrazinecarbodithioate 21 and pyrrolidine in water for 6 h. 3-Chloromethyl-2-hydroxy-5-methylbenzaldehyde was synthesised by following a modified published procedure. 22 Z-L-Proline 23 and β 3 -homoproline 24 were synthesised according to previously reported protocols. All utilised solvents were of HPLC grade and used without further purification.
Synthesis of ligand precursors
[1-(3-Formyl-2-hydroxy-5-methylbenzyl)-(R/S)-pyrrolidine-2yl]acetic acid methyl ester. To a solution of 3-chloromethyl-2hydroxy-5-methylbenzaldehyde (0.94 g, 5.09 mmol) in THF (10 mL) was added a solution of methyl (R/S)-pyrrolidin-2-ylacetate (0.79 g, 5.59 mmol) in methylene chloride (5 mL) followed by a solution of triethylamine (1.09 mL, 7.64 mmol) in THF (2 mL) and the reaction mixture was stirred at 60°C for 10 h. Then THF (100 mL) was added and the crystallised triethylammonium chloride was filtered off. The orange solution was concentrated under reduced pressure and purified by column chromatography by using a 1 : 1 mixture of ethyl acetate/hexane as the eluent (R f = 0.14). The yellow oil was dried in vacuo. Yield: 1.18 g, 80.0%. 1 To a solution of 2-hydroxy-3-methyl-(S)-pyrrolidine-2-carboxylate-5-methylbenzaldehyde (1.7 g, 6.5 mmol) in ethanol (30 mL) under stirring was added a solution of 4-Npyrrolidine-3-thiosemicarbazide (0.94 g, 6.5 mmol) in ethanol (10 mL). The reaction mixture was refluxed at 85°C for 1 h. Upon cooling to room temperature, the precipitate was filtered off, washed with cold ethanol (5 mL) and dried in vacuo overnight. Yield: 0.7 g, 25.2%; no m.p., decomposition without melting, onset at 180°C. Anal. Calcd for C 19 in ethanol (30 mL) was added 4-N-pyrrolidine-3-thiosemicarbazide (0.20 g, 1.37 mmol) in water (30 mL). The solution was stirred at 80°C for 24 h and cooled to room temperature. The beige precipitate was filtered off, washed with diethyl ether (2 mL) and dried in vacuo. Yield: 0.24 g, 43.0%; no m.p., decomposition without melting, onset at 170°C. Anal. Calcd for C 20 For the atom labeling scheme and assignment of NMR resonances see Chart 1.
Synthesis of metal complexes
. To a solution of H 2 L 1 ·2H 2 O (0.20 g, 0.47 mmol) in ethanol (20 mL) was added a solution of NiCl 2 ·6H 2 O (0.12 g, 0.50 mmol) in ethanol (5 mL) and the reaction mixture was stirred at room temperature for 2 h. The solvent was removed on a rotary evaporator under reduced pressure. The residue was dissolved in methanol (2 mL) and the product precipitated by the addition of diethyl ether (20 mL) was filtered off, washed with diethyl ether (5 mL) and dried in air. Yield: 0.21 g, 82.2%; no m.p., decomposition without melting, onset at 260°C. Anal. Calcd for C 19 (20 mL) was added a solution of PdCl 2 (0.09 g, 0.51 mmol) in ethanol (5 mL) and the reaction mixture was refluxed for 1 h. The solvent was removed on a rotary evaporator under reduced pressure. The residue was dissolved in methanol (2 mL) and the product precipitated by the addition of diethyl ether (20 mL) was filtered off, washed with diethyl ether (5 mL) and dried in air. Yield: 0.13 g, 47.2%; no m.p., decomposition without melting, onset at 220°C. Anal. Calcd for C 19 13 (20 mL) was added a solution of CuCl 2 ·2H 2 O (0.09 g, 0.53 mmol) in ethanol (5 mL) and the reaction mixture was stirred at room temperature for 2 h. The solvent was removed on a rotary evaporator under reduced pressure. The residue was dissolved in methanol (2 mL) and the product precipitated by the addition of diethyl ether (20 mL) was filtered off, washed with diethyl ether (5 mL) and dried in air. Yield: 0.15 g, 59.4%; no m.p., decomposition without melting, onset at 220°C. Anal. Calcd for C 19 Crystallographic structure determination X-ray diffraction measurements of H 2 L 1 and 1 were performed on a Bruker D8 Venture, while those of 2 and 4 were performed on Bruker X8 APEXII CCD and STOE diffractometers, respectively, both equipped with an Oxford Cryosystem cooler device. The single crystals of H 2 L 1 , 1, 2 and 4 were positioned at 35, 35, 40 and 40 mm from the detector, and 1401, 1071, 636 and 2136 frames were measured, each for 20, 10, 20 and 38 s over 0.4, 0.5, 1 and 1°scan width, respectively. The data were processed using SAINT software. 25 Crystal data, data collection parameters, and structure refinement details are given in Table 1 . The structures were solved by direct methods and refined by full-matrix least-squares techniques. All non-hydrogen atoms were refined with anisotropic displacement parameters. H atoms were inserted in calculated positions and refined with a riding model. The pyrrolidine and proline rings in one of the two crystallographically independent molecules of 1 were found to be disordered over two positions with an s.o.f. of 0.65 : 0.35 and 0.75 : 0.25, respectively, without using any restraints implemented in SHELXL2014. SADI and EADP restraints were applied to resolve the static disorder observed in the co-crystallised solvent molecules in H 2 L 1 . The single crystal of 4 was weakly diffracting and the resolution of the collected X-ray data was estimated to be 1.02 Å. Nevertheless, the structure could be solved and the electron density of the molecule is well-defined, allowing for the determination of the atomic connectivity and refinement with anisotropic temperature factors for all non-hydrogen atoms. The following software programs and computer were used: structure solution, SHELXS-97; refinement, SHELXL-97; 26 molecular diagrams, ORTEP-3; 27 computer, Intel CoreDuo. CCDC 1471829-1471831 and 1492553.
One-dimensional 1 H and 13 C NMR and two-dimensional 1 H-1 H COSY and 1 H-13 C HMBC NMR spectra were recorded on two Bruker Avance III spectrometers at 500.32 or 500.10 ( 1 H) and 125.82 or 125.76 ( 13 C) MHz, respectively, at room temperature, and using standard pulse programs. 1 H and 13 C shifts are quoted relative to the solvent residual signals.
Electrospray ionisation mass spectrometry (ESI-MS) was carried out with a Bruker Esquire 3000 instrument and the samples were dissolved in methanol. Elemental analyses were performed at the Microanalytical Laboratory of the University of Vienna with a Perkin Elmer 2400 CHN Elemental Analyzer (Perkin Elmer, Waltham, MA). IR spectra were recorded on a Bruker Vertex 70 Fourier transform IR spectrometer by using the ATR technique. UV-vis absorption spectra were recorded on a JASCO V770 spectrophotometer, while CD spectra were recorded on a JASCO J1500 spectrometer. The spectra were recorded at room temperature in a cuvette with 10 mm path length. Cytotoxic effects of the test compounds were determined by means of a colorimetric microculture assay [MTT assay; MTT = 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide]. Cisplatin (Teva) was used as a positive control. Cells were harvested from culture flasks by trypsinization and seeded by using a pipetting system (Biotek Precision XS Microplate Sample Processor) at densities of 3 × 10 3 (A549), 1 × 10 3 (CH1) and 2 × 10 3 (SW480) in 100 μL per well aliquots in 96well microculture plates. For 24 h, cells were allowed to settle and resume proliferation. Test compounds were then dissolved in DMSO, diluted in complete culture medium and added to the plates where the final DMSO content did not exceed 0.5%. After 96 h of drug exposure, the medium was replaced with 100 μL per well of a 1 : 7 MTT/RPMI 1640 mixture (MTT solution, 5 mg mL −1 of MTT reagent in phosphate-buffered saline; RPMI 1640 medium, supplemented with 10% heat-inactivated fetal bovine serum and 4 mM L-glutamine), and plates were incubated at 37°C for a further 4 h. Subsequently, the solution was removed from all wells, and the formazan crystals formed by viable cells were dissolved in 150 μL of DMSO per well. Optical densities at 550 nm were measured with a microplate reader (Biotek ELx808) by using a reference wavelength of 690 nm to correct for unspecific absorption. The quantity of viable cells was expressed relative to untreated controls, and 
Antiproliferative activity
where n is the number of reflections and p is the total number of parameters refined. 50% inhibitory concentrations (IC 50 ) were calculated from concentration-effect curves by interpolation. Evaluation is based on the means from three independent experiments. A slightly modified procedure was used to test the antiproliferative effect in NIH/3T3 murine embryonal fibroblast cells, which is provided in the ESI. †
Mechanisms of cell death: assay for apoptosis induction
The assay was carried out using an Annexin V-FITC Apoptosis Detection Kit (Cat. No. PF 032) from Calbiochem according to the manufacturer's instructions. The concentration of the A549 cell suspension was adjusted to approximately 0.5 × 10 6 cells per mL in MEM and the cell suspension was distributed in 1 mL aliquots into a 24-well plate, and then incubated overnight at 37°C and 5% CO 2 . The next day, the medium was removed and replaced by 1 mL MEM containing the compounds except the control samples. A549 cells were incubated in the presence of the compounds at 20 μM in the 24-well plate at 37°C for 3 h, and 12H-benzo[α]phenothiazine (M627) 28 and cisplatin (Teva) at 20 μM were used as positive controls. After the incubation period the samples were washed with PBS and fresh MEM medium was added to the samples. The cells were incubated overnight at 37°C and 5% CO 2 . The next day, 200 μL 0.25% Trypsin (Trypsin-Versen) was added to the samples until cells appeared detached followed by the addition of 400 μL of MEM supplemented with 10% bovine serum. The cells were collected in Eppendorf tubes and centrifuged at 2000g for 2 min. The harvested cells were resuspended in fresh serum free MEM culture medium. After this step, the apoptosis assay was carried out according to the rapid protocol of the kit. The fluorescence was analysed immediately using a ParTec CyFlow flow cytometer (Partec GmbH, Münster, Germany).
Results and discussion
Synthesis and characterization of proligands and metal complexes
The chiral 2-hydroxy-3-methyl-(S)-pyrrolidine-2-carboxylate-5methylbenzaldehyde 4-N-pyrrolidine-3-thiosemicarbazone was prepared in three steps as described recently for the unsubstituted at the terminal nitrogen atom of the thiosemicarbazide moiety derivative. 19 First, 3-chloromethyl-2-hydroxy-5-methylbenzaldehyde 21 was allowed to react with L-proline methyl ester hydrochloride in the presence of triethylamine with the formation of the desired conjugate. Condensation reaction of this latter compound with 4-N-pyrrolidine-3-thiosemicarbazide 16 followed by hydrolysis of the methyl ester group afforded the corresponding TSC coupled via a methylene group to L-Pro moiety (H 2 L 1 ). The formation of desired species has been confirmed by 1 H and 13 C NMR measurements, as well as by ESI mass spectrometry. The mass spectrum recorded in the positive ion mode showed peaks at m/z 391 due to [M + H] + ions. Aqueous solution of H 2 L 1 at neutral pH is optically active. The racemate H 2 L 2 was obtained similarly by using the (R/S)-β 3 -homoproline methyl ester instead of the L-proline methyl ester hydrochloride. The latter was prepared via a fourstep procedure by exploring the Arndt-Eistert reaction as a common method of homologisation of an α-amino acid into β-amino acid (e.g., proline to β 3 -homoproline) as shown in Scheme S1. † 29 Briefly, in the first step the secondary amine in L-proline was protected by reaction with benzyl chloroformate in aqueous KOH solution. Then the N-protected L-proline was converted into the acyl halide by treating with excess oxalylchloride in dichloromethane followed by methylation with (trimethylsilyl)diazomethane and formation of the α-diazotylketone. This latter conversion, known as Wolff rearrangement, is the key step involving the insertion of a CH 2 -group. 29 The α-diazotylketone was further rearranged in dry methanol in the presence of silver benzoate and triethylamine. Finally the amino group was deprotected with H 2 in the presence of 10% PdC in dry methanol. The synthesis can be performed on a large scale with 51% overall yield of β 3 -homoproline methyl ester. The reaction of β 3 -homoproline methyl ester with 3-chloromethyl-2hydroxy-5-methylbenzaldehyde in THF/CH 2 Cl 2 afforded [1-(3-formyl-2-hydroxy-5-methylbenzyl)-(R/S)-pyrrolidin-2-yl]acetic acid methyl ester, which was purified by column chromatography to give an orange oil in 80% yield. Condensation of this product with 4-N-pyrrolidine-3-thiosemicarbazide accompanied by hydrolysis of the ester group resulted in H 2 L 2 in 43% yield. The formation of the desired ligand precursor was confirmed by ESI mass spectrometry, which showed the presence of a peak with m/z 405, attributed to [M + H] + ions, as well as by 1 ESI mass spectra of 1 and 3 recorded in the positive ion mode exhibit a strong peak at m/z 447.26 and m/z 452, which can be assigned to [Ni(HL 1 )] + and [Pd(HL 1 )] + , respectively, while the negative ion mass spectrum of 2 contains a strong signal at m/z 530.93 due to [Pd(L 1 )Cl] − . By reaction of a methanolic solution of CuCl 2 ·2H 2 O with H 2 L 2 the complex [Cu(H 2 L 2 )-Cl 2 ]·H 2 O was obtained in 55% yield. ESI mass spectra, recorded in the positive ion mode, showed the presence of a strong peak at m/z 466.31 attributed to [Cu II (HL 2 )] + , while in the negative ion mode, peaks with m/z 464.10 and 500.05 due to [Cu II (L 2 -H)] − and [Cu II (L 2 )Cl] − , respectively, were observed, in agreement with the X-ray diffraction structure (vide infra). Fig. 1 shows the structure of the chiral ligand precursor H 2 L 1 with selected bond distances and angles quoted in the legend. The compound crystallizes in the monoclinic space group C2 with two crystallographically independent molecules in the asymmetric unit. The conformation adopted by H 2 L 1 is very close to that of the ligand in complexes 1 and 2 (vide infra). The prolinic moiety is in the zwitterionic form, which makes the atom N4a in addition to C14a chiral. A strong intramolecular hydrogen bonding O1a-H⋯N1a with an O1a⋯N1a of 2.595(4) Å and an O1a-H⋯N1a of 143.4°is evident in the structure of H 2 L 1 . The atoms N2a and N4a act as proton donors to O3a i (−x + 1, y, −z + 1) and O2b i (−x + 1, y, −z + 1), respectively, forming hydrogen bonds N2a-H⋯O3a i and N4a-H⋯O2b i with an N2a⋯O3a i of 2.736(5) Å, an N2a-H⋯O3a i of 155.5°and an N4a⋯O2b i of 2.857(5) Å, an N2a-H⋯O3a i of 136.7°.
X-ray crystallography
The results of X-ray diffraction studies of 1, 2 and 4 are shown in Fig. 2 and 3 . Compounds 1 and 2 are isostructural and crystallised in the noncentrosymmetric monoclinic space group P2 1 as pure enantiomers, as also confirmed by the Flack parameters quoted in Table 1 , with two chiral atoms of the same configuration (vide infra). Complex 4 crystallised in the centrosymmetric monoclinic space group C2/c. The asymmetric unit in 1 and 2 consists of two crystallographically independent cations [M(H 2 L 1 )Cl] + (M = Ni, Pd) and two chloride counterions, where H 2 L 1 is the charge-neutral proline-thiosemicarbazone hybrid, while that of 4 consists of one complex, [Cu(H 2 L 2 )Cl 2 ]. The ligands H 2 L 1 in 1 and 2 and H 2 L 2 in 4 act as a tridentate binding to the metal(II) via the phenolate oxygen atom O1, the nitrogen atom N1 and the thione sulfur S1 as shown in Fig. 2 and 3 for one of the two crystallographically independent cations [Ni(H 2 L 1 )Cl] + , [Pd(H 2 L 1 )Cl] + and the complex [Cu(H 2 L 2 )Cl 2 ]. The ligands are deprotonated at O1, but protonated at N4, so that the overall protonation level does not change. Protonation at N4 makes this atom chiral (S configuration) in 1 and 2. The second chiral centre C14 has the same S configuration. According to the literature, the nitrogen atom of the L-prolinate ligand or moiety upon coordination to metal ions or protonation in most cases adopts the same configuration as the asymmetric carbon atom, 30 although cases where the two atoms adopt opposite configurations are also known. 31 The coordination geometry of nickel(II) and palladium(II) is square-planar. The fourth coordination place is occupied by a chlorido ligand.
The overall positive charge of the complex cation is counterbalanced by another chloride ion.
The Pd-O, Pd-N, Pd-Cl and Pd-S bond lengths in 2 are well-comparable to those found in the complex [Pd(HSal4Et) Cl]·H 2 O, where H 2 Sal4Et = 2-hydroxybenzaldehyde 4-Nethylthiosemicarbazone, at 2.019(2), 1.965(2), 2.3078(8) and 2.2456(9) Å, respectively. 32 The protonated atom N4a in cation A acts as a proton donor in bifurcated hydrogen bonding interaction to O2a and Cl2 i (x − 1, y, z − 1), while N4b in cation B acts as a proton donor to O1B and O2B as shown in Fig. S1 . † In addition, strong hydrogen bonding interactions N2a-H⋯Cl2a [N2a⋯Cl2a 3.157(6) Å, N2a-H⋯Cl2a 160.2°], N2b-H⋯Cl2b ii (−x + 1, y − 0.5, −z + 1) [N2b⋯Cl2b ii 3.162(0) Å, N2b-H⋯Cl2b ii 156.5°] and O3b-H⋯Cl2a ii (−x + 1, y + 0.5, −z + 1) [O3b⋯Cl2a ii 2.926(0) Å, O3b-H⋯Cl2a ii 170.4°] are evident in the crystal structure of 2. Closely similar hydrogen bonding interactions for 1 are quoted in Table S1 . † A feature of note is the presence of short intermolecular contacts Ni⋯S and Pd⋯S between neighbouring complex cations of ca. 3.69-3.70 and 3.59-3.60 Å, respectively, as shown in Fig. S2 and S3 . † The interplanar separation between the aromatic rings of the interacting species is ca. 3.25 and 3.16 Å, in 1 and 2, respectively. Formation of short contacts of this type is not characteristic of the complex [Pd(HSal4Et)Cl]·H 2 O mentioned previously.
The coordination polyhedron of copper(II) in 4 is best described as a square-pyramid (τ = 0.15). 33 The tridentate ligand H 2 L 2 and one chloride occupy the basal plane, while the second chlorido ligand occupies the apical position. Comparison of the bond lengths Cu-Cl1 and Cu-Cl2 (see the legend to Fig. 3 ) indicates markedly weaker binding of the apical chlorido ligand to copper(II). The protonated atom N4 acts as a proton donor in intramolecular bifurcated hydrogen bonding interaction to O1 and Cl2 [N4⋯O1 2.624(10) Å, N4-H⋯O1 132.5°; N4⋯Cl1 3.684(8) Å, N4-H⋯Cl1 149.0°]. In addition, strong intermolecular hydrogen bonding interactions N2-H⋯Cl2 ii (−x + 1, −y + 1, −z) [N2⋯Cl2 ii 3.197 
NMR spectroscopy
The 1 H NMR spectra of 2 and H 2 L 1 have been analysed. The 2D homonuclear COSY 1 H-1 H and heteronuclear HMBC 1 H-13 C correlations were applied to assign the NMR signals (see Fig. S4 †) . The NMR spectra of H 2 L 1 are consistent with the X-ray diffraction structure. We note here the particular splitting of protons of the methylene group which connects the aromatic and proline rings. The two protons C 8 H a and C 8 H b are magnetically inequivalent due to their different spatial orientation with respect to the bond C 8 H 2 -N 4 C 9 C 12 . The simu- (7), Ni1a-N1a 1.848(10), Ni1a-S1a 2.147(3), C1a-O1a 1.300 (14) , N1a-N2a 1.392(12), N2a-C8a 1.340 (15) , C8a-S1a 1.708(13), C8a-N3a 1.311 (15) ; O1a-Ni1a-N1a 93.6(4), N1a-Ni1a-S1a 88.8 (3) . Selected bond distances (Å) and bond angles (°) [Pd(H 2 L 1 )Cl]Cl: Pd1a-Cl1a 2.3049(12), Pd1a-O1a 2.016(3), Pd1a-N1a 1.976(4), Pd1a-S1a 2.2470(11), C1a-O1a 1.320(5), N1a-N2a 1.382(5), N2a-C8a 1.350(5), C8a-S1a 1.722(5), C8a-N3a 1.318(5); O1a-Pd1a-N1a 92.39 (14) , N1a-Pd1a-S1a 86.53 (11) . The approximate dihedral angle for the conformation adopted in this case (Fig. 4, right) can be calculated by using the Karplus equation: 34, 35 3 J ¼ 8:5 cos 2 φ À 0:28 0° φ 90°9 :5 cos 2 φ À 0:28 90° φ 180°
The conformation of the proline ring in H 2 L 1 is consistent with previously reported data. 36, 37 As can be seen from Fig. 3 , the C 8 H 2 group in 2 has a different splitting pattern and chemical shift in comparison with H 2 L 1 . A similar change in chemical shift is observed for C 9 H. The downfield shift of proton resonances of the proline ring in 2 can be related to double protonation of the proline group (amine nitrogen and carboxylato groups) in the complex in comparison with single protonation in the zwitterionic form of the ligand precursor. The single crystal X-ray analysis shows that the proline nitrogen (N 4 ) is protonated in both H 2 L 1 and in 2. In 2 an additional protonation of the ligand at O3a was also proved by X-ray analysis. The protonation state of N4 is also preserved in solution (DMSO), in accord with the additional splitting of two protons of the C 8 H 2 group. The modification in the splitting pattern of C 8 H 2 signals can be associated with the change in spatial orientation of the C 8 H 2 group after coordination. According to the simulation of the NMR spectra the best fit between theoretical and experimental spectra indicates the same magnitude of vicinal coupling constant between the protons C 8 H a and HN 4 and C 8 H b and HN 4 and corresponds to the dihedral angle of 40°( 3 J C8H-HN4 = 5.0 Hz) ( Fig. 3 ). This value corresponds to an average conformational position upon rotation around the C 8 H 2 -N 4 C 9 C 12 single bond on the time scale of NMR spectroscopy. The protonation also affects the splitting of the α proton (C 9 H), and all 1 H NMR resonances are upfield shifted (δ C8Ha = 4.419, δ C8Hb = 4.307 and δ C9H = 4.509 ppm). The HN 4 signal appears in the 1 H NMR spectra at 9.97 ppm as a broad signal (13.0 Hz) as a consequence of splitting and chemical exchange in solution. The correlations between HN 4 with C 8 H 2 and C 9 H were confirmed by the presence of cross peaks in COSY 1 H-1 H spectra (Fig. S5 †) . The geminal 2 J Ha-Hb constant is of the same magnitude of 13.0 Hz.
Dissolution of the red solid of 1 in methanol resulted in the formation of a green solution suggesting a change in coordination geometry of nickel(II). The 1 H NMR spectrum of 1 showed broad lines, which indicated the presence of paramagnetic species in solution. We determined the effective magnetic moment of 1 in CD 3 OD (1.58 × 10 −2 M) at 298 K by using the NMR method of Evans. 38 The value amounts to 3.26 B.M., which is typical for octahedral nickel(II) complexes with d 8 electronic configuration. 39 The CD spectrum of a methanolic solution of 1 (Fig. 4, green trace) indicates the presence of asymmetric centres in the molecule. The CD signals are correlated to the absorption bands for the ligand precursor and show the absence of CD signals in the visible region. The absence of CD signals in the visible region of the spectrum indicates that the proline moiety with its two asymmetric centres is not bound to the nickel(II) in solution.
The electronic absorption spectrum of 1 in methanol in the visible and NIR regions shows three bands with a λ max of 865 (11 560 cm −1 ), 770 (12 987 cm −1 ) and 620 (16 129 cm −1 ) nm ( Fig. 5 ) which can be attributed to 3 A 2g → 3 T 2g (F), 3 A 2g → 1 E g (D) and 3 A 2g → 3 T 1g (F) transitions of Ni(II) in an octahedral environment, respectively. 40 Spin-allowed transitions are known to give broad absorption bands, while spin-forbidden transitions are usually sharp. 41 For nickel(II) (d 8 ) in an octahedral environment 3 A 2g is the ground term and the spin allowed transition 3 A 2g → 3 T 2g (F) is equal to the value of the crystal field splitting (10 Dq). 42 The value (11 560 cm −1 ) is consistent with those reported for octahedral nickel(II) complexes. 43 The third characteristic transition 3 A 2g → 3 T 1g (P) is expected in the range of 19 000-27 000 cm −1 , which is obscured by strong intraligand absorption bands.
Stability in aqueous solution
Quite recently we reported on complex formation reactions of copper(II) with L-Pro-STSC in 30% (w/w) DMSO/H 2 O. 19 Several determined thermodynamic cumulative stability constants indicate significantly high stability of copper(II) complexes, which are closely related to those studied in this work (3 and 4) . In addition, we monitored the behaviour of 4 in aqueous solution with 1% DMSO by UV-vis spectroscopy. The data ( Fig. S6 and S7 †) indicate that the complex remains intact over 24 h in solution. copper(II) complex [Cu(D-Pro-STSC)Cl]Cl, 19 which is closely related to 3, we can conclude that the role of coordination geometry in the underlying mechanism of cytotoxicity seems to be marginal, if any, when we compare the IC 50 values of 1-3 with those of H 2 L 1 . This conclusion remains valid if we exclude 1 from the series due to the change in coordination geometry in solution to octahedral. Substitution at the terminal nitrogen atom of the thiosemicarbazide moiety, namely pyrrolidine vs. NH 2 , has a marked effect on cytotoxicity as well, which can be compared with that of metal coordination. A 23-(CH1) and more than 10-fold (SW480) decrease of IC 50 values is achieved via this substitution for metal-free compounds, and a 5-to 5.5fold decrease is achieved for the same structural modification in copper(II) complexes. 19 Insertion of a CH 2 group between the pyrrolidine ring and the COOH group of the amino acid moiety reduces markedly the antiproliferative activity of both the ligand precursor and its copper(II) complex. Based on IC 50 values a maximal 8-fold drop in cytotoxicity was observed on going from 3 to 4. The antiproliferative activity of complex 3 is slightly lower, but comparable to the clinical drug cisplatin. Compounds found to be active (H 2 L 1 , H 2 L 2 , complexes 3 and 4) in human cancer cells were tested for their antiproliferative activity in the noncancerous murine embryonal fibroblast (NIH/3T3) cell line as well. They showed no selectivity as their IC 50 values for the normal cells are comparable to those obtained for the cancer cells.
The mechanism of cytotoxicity induced by H 2 L 1 , H 2 L 2 and complexes 3 and 4 was assessed by analysis of A549 cells stained with Annexin-V and propidium iodide (PI) using flow cytometry. Compounds M627 and cisplatin were used as positive controls. Apoptosis is a fundamental mode of cell death which performs a regulatory function during normal development, in tissue homeostasis, and in some disease processes. In normal viable cells phosphatidylserine (PS) is located on the cytoplasmic surface of the cell membrane. Upon induction of apoptosis, rapid alterations in the organisation of phospholipids in most cell types occur, leading to exposure of PS on the cell surface. In this assay a fluorescein isothiocyanate (FITC) conjugate of Annexin-V (a Ca-dependent phospholipidbinding protein with a high affinity for PS) was used, allowing detection of apoptosis. Since membrane permeabilisation is observed in necrosis, necrotic cells will also bind Annexin-V-FITC. PI is used to distinguish between viable, early apoptotic and necrotic or late apoptotic cells. Necrotic cells bind Annexin-V-FITC and stain with PI, while PI is excluded from viable (FITC negative) and early apoptotic (FITC positive) cells. In the absence of phagocytosis the final stages of apoptosis involve necrotic-like disintegration of the total cell; thus cells in late apoptosis will be labeled with both FITC and PI. The fluorescence of PI (FL3) is plotted versus Annexin-V fluorescence (FL1) as shown in Fig. 6 for the positive controls and complex 4. The early apoptotic cells in percentage were compared for the tested compounds ( Fig. S8 †) . Elevated early apoptosis was observed for one of the studied ligand precursors (H 2 L 2 ) and complexes 3 and 4 as well as for cisplatin and M627 compared with the DMSO control. According to these Table 2 Inhibition of cancer cell growth of ligand precursors and metal complexes in human non-small cell lung (A549) carcinoma, ovarian (CH1), colon (SW480) and NIH/3T3 mouse embryonal fibroblast cells; 50% inhibitory concentrations (means ± standard deviations), obtained by the MTT assay (exposure time 96 h)
